Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum neurotoxin type A for sialorrhea in central nervous system diseases
2015-000682-30Phase 3Completed
- Sponsor
- Tartu University Hospital
- Start
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of botulinum toxin type A in hypersalivation (2 arms), sponsored by Tartu University Hospital. Primary endpoint: Change in salivary composition and microflora after BNT-A versus controls. Started Apr 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
hypersalivation
Beyond the preview
Go deeper on 2015-000682-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000682-30.